비교리스트

 카트 문의
시장보고서
상품코드
1394139

아르보바이러스 검사 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2031년) - 검사 유형별, 최종 사용자별, 지역별

Arbovirus Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
발행일: | 리서치사: Fairfield Market Research | 페이지 정보: 영문 172 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 아르보바이러스 검사 시장 규모는 2024년부터 2031년까지 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 아르보바이러스는 주로 모기나 진드기와 같은 감염성 절지동물을 통해 인간에게 감염되며, 공중보건에 미치는 영향에 대한 관심이 높아지고 있습니다.

세계 아르보바이러스 검사 시장의 성장은 아르보바이러스의 급속한 출현, 공중보건 문제 증가, 정부의 통합적 이니셔티브 시행 등 여러 가지 요인에 의해 좌우됩니다. 이러한 촉진요인은 전체적으로 세계 아르보바이러스 검사 시장의 성장과 확장에 기여하고 있습니다.

공중 보건 실험실은 세계 아르보바이러스 검사의 최전선에 있습니다. 금액 측면에서 공중 보건 실험실 부문은 가장 큰 규모이며 평가 기간 동안 이 지위를 유지할 것으로 예상됩니다. 이 부문의 두드러진 수익 창출은 전체 아르보바이러스 검사 시장의 성장에 큰 기여를 하고 있습니다.

최종사용자 카테고리 중 병원 부문은 상당한 성장이 예상되며, 금액 기준 상위 부문 중 하나입니다. 성장률은 비교적 완만하지만, 아르보바이러스 검사에서 병원의 중요성이 높아짐에 따라 눈에 띄게 확대될 것으로 예상됩니다.

이 보고서는 세계의 아르보바이러스 검사 시장에 대해 조사했으며, 시장 개요와 함께 검사 유형별/최종사용자별/지역별 동향, 시장 진출기업의 경쟁 동향 등의 정보를 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

  • 시장 정의와 세분화
  • 시장 역학
  • 밸류체인 분석
  • Porter의 Five Forces 분석
  • COVID-19의 영향 분석
  • 우크라이나와 러시아 분쟁의 영향
  • 경제 개요
  • PESTLE 분석

제3장 세계의 아르보바이러스 검사 시장 전망, 2018년-2031년

  • 세계의 아르보바이러스 검사 시장 전망, 검사 유형별, 금액(10억 달러), 2018년-2031년
  • 세계의 아르보바이러스 검사 시장 전망, 최종사용자별, 금액(10억 달러), 2018년-2031년
  • 세계의 아르보바이러스 검사 시장 전망, 지역별, 금액(10억 달러), 2018년-2031년

제4장 북미의 아르보바이러스 검사 시장 전망, 2018년-2031년

제5장 유럽의 아르보바이러스 검사 시장 전망, 2018년-2031년

제6장 아시아태평양의 아르보바이러스 검사 시장 전망, 2018년-2031년

제7장 라틴아메리카의 아르보바이러스 검사 시장 전망, 2018년-2031년

제8장 중동 및 아프리카의 아르보바이러스 검사 시장 전망, 2018년-2031년

제9장 경쟁 구도

  • 제조업체/최종사용자별 히트맵
  • 기업의 시장 점유율 분석, 2023년
  • 경쟁력 대시보드
  • 기업 개요
    • Thermo Fisher Scientific, Inc.
    • Diamedix Corporation
    • NovaTec Immundiagnostica GmbH
    • Euroimmun AG
    • Focus Diagnostics(Member of DiaSorin Group)
    • Standard Diagnostics, Inc.
    • IBL International(A Member of the Tecan Group) Alere

제10장 부록

LSH 23.12.19

The global market for arbovirus testing is poised for substantial growth over the forecast period from 2024 to 2031, according to a comprehensive market study. Arboviruses, which are primarily transmitted to humans through infected arthropods like mosquitoes and ticks, have gained increasing attention due to their public health impact. The research report delves into the latest trends, opportunities, drivers, and challenges influencing the market, offering valuable insights for industry stakeholders.

Expanding Horizons in Arbovirus Testing

The scope of this research encompasses a thorough analysis of end-user preferences, competitive dynamics, regional outlook, and various test types within arbovirus testing. Asia-Pacific and Middle East & Africa emerge as promising markets, driven by their substantial populations at risk of arbovirus infections and high arbovirus prevalence. Manufacturers are focused on advancing diagnostic techniques, extending their applicability beyond a few infections, thereby fueling market growth.

Key Drivers of Growth

The growth of the global arbovirus testing market hinges on several factors, including the rapid emergence of arboviruses, increasing public health challenges, and the implementation of integrated government initiatives. These drivers collectively contribute to the growth and expansion of the arbovirus testing market on a global scale.

Dominance of Public Health Laboratories

Public health laboratories have been at the forefront of arbovirus testing efforts worldwide. In terms of value, the public health laboratory segment is the largest and is expected to maintain this position throughout the assessment period. Its remarkable revenue generation significantly contributes to the overall growth of the arbovirus testing market.

Hospitals on the Rise

The hospital segment within the end-user category is anticipated to experience substantial growth, positioning itself as one of the top segments in terms of value. Despite a comparatively slower growth rate, it is projected to expand noticeably, reflecting the increasing importance of hospitals in arbovirus testing.

Market Segmentation

The market segmentation for the arbovirus testing industry includes test types, end users, and regions:

By Test Type:

  • 1. ELISA-Based Tests
  • 2. RT-PCR Based Tests

By End User:

  • 1. Hospitals
  • 2. Public Health Laboratories
  • 3. Diagnostic Centers
  • 4. Others

By Region:

  • 1. North America
  • 2. Latin America
  • 3. Europe
  • 4. Asia Pacific (APAC)
  • 5. Middle East and Africa (MEA)

The global arbovirus testing market is set to witness significant growth and innovation in the coming years, with a range of opportunities and challenges for businesses in this sector. Stakeholders, including manufacturers, healthcare providers, and public health agencies, are gearing up to address the growing threat of arbovirus infections and contribute to the advancement of diagnostic capabilities.

Table of Contents

1. Executive Summary

  • 1.1. Global Arbovirus Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Arbovirus Testing Market Outlook, 2018 - 2031

  • 3.1. Global Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. ELISA-Based Tests
      • 3.1.1.2. RT-PCR Based Tests
  • 3.2. Global Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Public Health Laboratory
      • 3.2.1.3. Diagnostic Centers
      • 3.2.1.4. Others
  • 3.3. Global Arbovirus Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Arbovirus Testing Market Outlook, 2018 - 2031

  • 4.1. North America Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. ELISA-Based Tests
      • 4.1.1.2. RT-PCR Based Tests
  • 4.2. North America Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals
      • 4.2.1.2. Public Health Laboratory
      • 4.2.1.3. Diagnostic Centers
      • 4.2.1.4. Others
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.2. U.S. Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 4.3.1.3. Canada Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.4. Canada Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Arbovirus Testing Market Outlook, 2018 - 2031

  • 5.1. Europe Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. ELISA-Based Tests
      • 5.1.1.2. RT-PCR Based Tests
  • 5.2. Europe Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals
      • 5.2.1.2. Public Health Laboratory
      • 5.2.1.3. Diagnostic Centers
      • 5.2.1.4. Others
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.2. Germany Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.3. U.K. Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.4. U.K. Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.5. France Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.6. France Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.7. Italy Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.8. Italy Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.9. Turkey Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.10. Turkey Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.11. Russia Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.12. Russia Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Arbovirus Testing Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. ELISA-Based Tests
      • 6.1.1.2. RT-PCR Based Tests
  • 6.2. Asia Pacific Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals
      • 6.2.1.2. Public Health Laboratory
      • 6.2.1.3. Diagnostic Centers
      • 6.2.1.4. Others
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.2. China Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.3. Japan Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.4. Japan Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.5. South Korea Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.6. South Korea Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.7. India Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.8. India Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Arbovirus Testing Market Outlook, 2018 - 2031

  • 7.1. Latin America Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. ELISA-Based Tests
      • 7.1.1.2. RT-PCR Based Tests
  • 7.2. Latin America Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Hospitals
      • 7.2.1.2. Public Health Laboratory
      • 7.2.1.3. Diagnostic Centers
      • 7.2.1.4. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.2. Brazil Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.3. Mexico Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.4. Mexico Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.5. Argentina Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.6. Argentina Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Arbovirus Testing Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. ELISA-Based Tests
      • 8.1.1.2. RT-PCR Based Tests
  • 8.2. Middle East & Africa Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals
      • 8.2.1.2. Public Health Laboratory
      • 8.2.1.3. Diagnostic Centers
      • 8.2.1.4. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.2. GCC Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.3. South Africa Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.4. South Africa Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.5. Egypt Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.6. Egypt Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.7. Nigeria Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.8. Nigeria Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs by End User Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Diamedix Corporation
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. NovaTec Immundiagnostica GmbH
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Euroimmun AG
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Focus Diagnostics (Member of DiaSorin Group)
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Standard Diagnostics, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. IBL International (A Member of the Tecan Group)
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Alere
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제